

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 6.60231928 |
| 2 | polyketide metabolic process (GO:0030638) | 6.60231928 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.60231928 |
| 4 | protein localization to kinetochore (GO:0034501) | 5.48260181 |
| 5 | nuclear pore complex assembly (GO:0051292) | 5.08245633 |
| 6 | histone H4-K12 acetylation (GO:0043983) | 5.03314743 |
| 7 | heterochromatin organization (GO:0070828) | 5.02713290 |
| 8 | positive regulation of histone deacetylation (GO:0031065) | 4.95677977 |
| 9 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.92649560 |
| 10 | negative regulation of telomerase activity (GO:0051974) | 4.81583164 |
| 11 | maintenance of protein location in nucleus (GO:0051457) | 4.77485527 |
| 12 | negative regulation of epidermis development (GO:0045683) | 4.68781701 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.66444420 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.66359729 |
| 15 | histone H4-K5 acetylation (GO:0043981) | 4.65156152 |
| 16 | histone H4-K8 acetylation (GO:0043982) | 4.65156152 |
| 17 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.64454514 |
| 18 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.59631821 |
| 19 | nuclear pore organization (GO:0006999) | 4.57705146 |
| 20 | pre-miRNA processing (GO:0031054) | 4.53631415 |
| 21 | mitotic sister chromatid segregation (GO:0000070) | 4.47407420 |
| 22 | chromatin assembly (GO:0031497) | 4.45772125 |
| 23 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.41221599 |
| 24 | protein localization to chromosome, centromeric region (GO:0071459) | 4.39800530 |
| 25 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.39347471 |
| 26 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.39347471 |
| 27 | somite rostral/caudal axis specification (GO:0032525) | 4.28947089 |
| 28 | muscle organ morphogenesis (GO:0048644) | 4.28563299 |
| 29 | positive regulation of protein deacetylation (GO:0090312) | 4.26213311 |
| 30 | RNA stabilization (GO:0043489) | 4.12643410 |
| 31 | mRNA stabilization (GO:0048255) | 4.12643410 |
| 32 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.11863906 |
| 33 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.10967833 |
| 34 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.06122182 |
| 35 | sister chromatid segregation (GO:0000819) | 3.98844031 |
| 36 | pore complex assembly (GO:0046931) | 3.98290815 |
| 37 | regulation of response to osmotic stress (GO:0047484) | 3.93982952 |
| 38 | regulation of gene silencing by miRNA (GO:0060964) | 3.93969020 |
| 39 | regulation of gene silencing by RNA (GO:0060966) | 3.93969020 |
| 40 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.93969020 |
| 41 | maternal placenta development (GO:0001893) | 3.87131497 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.84383616 |
| 43 | histone H4-K16 acetylation (GO:0043984) | 3.81055575 |
| 44 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.79078851 |
| 45 | notochord development (GO:0030903) | 3.76570996 |
| 46 | interferon-gamma production (GO:0032609) | 3.72909743 |
| 47 | mannose metabolic process (GO:0006013) | 3.71198556 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70735908 |
| 49 | thymic T cell selection (GO:0045061) | 3.68609864 |
| 50 | rRNA transcription (GO:0009303) | 3.66988748 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.65189417 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65189417 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 3.57931673 |
| 54 | trophectodermal cell differentiation (GO:0001829) | 3.54195995 |
| 55 | cytidine metabolic process (GO:0046087) | 3.50464266 |
| 56 | cytidine catabolic process (GO:0006216) | 3.50464266 |
| 57 | cytidine deamination (GO:0009972) | 3.50464266 |
| 58 | primitive streak formation (GO:0090009) | 3.49625581 |
| 59 | hormone catabolic process (GO:0042447) | 3.49464152 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49292279 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48015302 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47880705 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46202253 |
| 64 | DNA duplex unwinding (GO:0032508) | 3.39102574 |
| 65 | DNA geometric change (GO:0032392) | 3.34006999 |
| 66 | regulation of translation in response to stress (GO:0043555) | 3.29358597 |
| 67 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.27714647 |
| 68 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.24498131 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 3.23966634 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23759521 |
| 71 | NLS-bearing protein import into nucleus (GO:0006607) | 3.23123133 |
| 72 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.22015556 |
| 73 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.21573493 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.20937950 |
| 75 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.20353375 |
| 76 | response to laminar fluid shear stress (GO:0034616) | 3.18826408 |
| 77 | mitotic chromosome condensation (GO:0007076) | 3.17612523 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16834823 |
| 79 | regulation of hippo signaling (GO:0035330) | 3.13639615 |
| 80 | T cell selection (GO:0045058) | 3.12213945 |
| 81 | negative thymic T cell selection (GO:0045060) | 3.11624240 |
| 82 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.10614654 |
| 83 | entrainment of circadian clock by photoperiod (GO:0043153) | 3.10399831 |
| 84 | apoptotic process involved in morphogenesis (GO:0060561) | 3.09174069 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08418641 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08418641 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 3.08418641 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08418641 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 3.08418641 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08418641 |
| 91 | positive T cell selection (GO:0043368) | 3.04644510 |
| 92 | omega-hydroxylase P450 pathway (GO:0097267) | 3.02799398 |
| 93 | negative T cell selection (GO:0043383) | 3.01762929 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 3.00209276 |
| 95 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.99776082 |
| 96 | DNA replication checkpoint (GO:0000076) | 2.99107267 |
| 97 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97938120 |
| 98 | DNA unwinding involved in DNA replication (GO:0006268) | 2.97025633 |
| 99 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96557049 |
| 100 | response to peptidoglycan (GO:0032494) | 2.95885997 |
| 101 | negative regulation of cell size (GO:0045792) | 2.95218446 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 2.93463880 |
| 103 | receptor recycling (GO:0001881) | 2.93213638 |
| 104 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91914141 |
| 105 | coenzyme catabolic process (GO:0009109) | 2.90204638 |
| 106 | embryonic process involved in female pregnancy (GO:0060136) | 2.89595096 |
| 107 | leukocyte aggregation (GO:0070486) | 2.89007581 |
| 108 | pinocytosis (GO:0006907) | 2.86690722 |
| 109 | retinoic acid receptor signaling pathway (GO:0048384) | 2.85542505 |
| 110 | detection of other organism (GO:0098543) | 2.85261762 |
| 111 | detection of bacterium (GO:0016045) | 2.84942768 |
| 112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83522656 |
| 113 | modulation by symbiont of host cellular process (GO:0044068) | 2.82740416 |
| 114 | negative regulation of telomere maintenance (GO:0032205) | 2.81526320 |
| 115 | chromosome condensation (GO:0030261) | 2.78998368 |
| 116 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.78841812 |
| 117 | histone H3-K4 methylation (GO:0051568) | 2.76033985 |
| 118 | response to dietary excess (GO:0002021) | 2.75718265 |
| 119 | cell migration involved in gastrulation (GO:0042074) | 2.75618203 |
| 120 | protein localization to endosome (GO:0036010) | 2.72599335 |
| 121 | regulation of telomerase activity (GO:0051972) | 2.72175651 |
| 122 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.69592756 |
| 123 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.69412076 |
| 124 | regulation of cilium movement (GO:0003352) | 2.68521454 |
| 125 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.68230277 |
| 126 | negative regulation of bone resorption (GO:0045779) | 2.67605795 |
| 127 | embryonic placenta development (GO:0001892) | 2.65694778 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65468212 |
| 129 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.64348858 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 2.64041393 |
| 131 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.63747101 |
| 132 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.63685529 |
| 133 | Peyers patch development (GO:0048541) | 2.63685529 |
| 134 | spindle assembly (GO:0051225) | 2.63348210 |
| 135 | regulation of gene silencing (GO:0060968) | 2.63035703 |
| 136 | activation of Rac GTPase activity (GO:0032863) | 2.62968246 |
| 137 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62939504 |
| 138 | DNA conformation change (GO:0071103) | 2.62757032 |
| 139 | determination of adult lifespan (GO:0008340) | 2.62709322 |
| 140 | regulation of telomere maintenance (GO:0032204) | 2.62372058 |
| 141 | histone H3 acetylation (GO:0043966) | 2.62301123 |
| 142 | regulation of necroptotic process (GO:0060544) | 2.62022865 |
| 143 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.61774512 |
| 144 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.59831126 |
| 145 | response to interleukin-15 (GO:0070672) | 2.59538521 |
| 146 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.58425707 |
| 147 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.57345379 |
| 148 | negative regulation of histone methylation (GO:0031061) | 2.56302221 |
| 149 | cellular hyperosmotic response (GO:0071474) | 2.55035074 |
| 150 | mitochondrion distribution (GO:0048311) | 2.54834097 |
| 151 | regulation of mRNA stability (GO:0043488) | 2.54674316 |
| 152 | T cell migration (GO:0072678) | 2.53728327 |
| 153 | regulation of histone H3-K27 methylation (GO:0061085) | 2.53394881 |
| 154 | COPI coating of Golgi vesicle (GO:0048205) | 2.53375730 |
| 155 | Golgi transport vesicle coating (GO:0048200) | 2.53375730 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52872512 |
| 157 | modulation by virus of host process (GO:0019054) | 2.52798397 |
| 158 | negative regulation of myotube differentiation (GO:0010832) | 2.50572398 |
| 159 | positive regulation of B cell differentiation (GO:0045579) | 2.50345644 |
| 160 | negative regulation of necroptotic process (GO:0060546) | 2.49588019 |
| 161 | germinal center formation (GO:0002467) | 2.47869926 |
| 162 | histone H3-K36 demethylation (GO:0070544) | 2.45107404 |
| 163 | focal adhesion assembly (GO:0048041) | 2.44235901 |
| 164 | cell-substrate adherens junction assembly (GO:0007045) | 2.44235901 |
| 165 | negative regulation of viral release from host cell (GO:1902187) | 2.43845658 |
| 166 | cellular response to interleukin-4 (GO:0071353) | 2.42630536 |
| 167 | cellular response to virus (GO:0098586) | 2.40505748 |
| 168 | adherens junction assembly (GO:0034333) | 2.37656088 |
| 169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.34633156 |
| 170 | natural killer cell differentiation (GO:0001779) | 2.33264276 |
| 171 | response to interleukin-4 (GO:0070670) | 2.30604491 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 2.30092268 |
| 173 | regulation of early endosome to late endosome transport (GO:2000641) | 2.29389605 |
| 174 | regulation of integrin activation (GO:0033623) | 2.28519380 |
| 175 | regulation of B cell differentiation (GO:0045577) | 2.27237258 |
| 176 | regulation of leukocyte degranulation (GO:0043300) | 2.27015317 |
| 177 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.26025474 |
| 178 | negative regulation of interleukin-12 production (GO:0032695) | 2.25163845 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.25106639 |
| 180 | type I interferon signaling pathway (GO:0060337) | 2.23895770 |
| 181 | cellular response to type I interferon (GO:0071357) | 2.23895770 |
| 182 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.23806282 |
| 183 | response to type I interferon (GO:0034340) | 2.22820329 |
| 184 | regulation of defense response to virus by virus (GO:0050690) | 2.21459444 |
| 185 | detection of external biotic stimulus (GO:0098581) | 2.21276069 |
| 186 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.20499475 |
| 187 | regulation of necrotic cell death (GO:0010939) | 2.20098086 |
| 188 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.20070738 |
| 189 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.20051469 |
| 190 | myeloid dendritic cell differentiation (GO:0043011) | 2.19888183 |
| 191 | regulation of monocyte differentiation (GO:0045655) | 2.19244662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.09995507 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.88865823 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.88865823 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.88865823 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80654264 |
| 6 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.29861549 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.86304120 |
| 8 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.78703871 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59576856 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.38231402 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.36126451 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32415960 |
| 13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.31063074 |
| 14 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.25288983 |
| 15 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.14505324 |
| 16 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04896121 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02327359 |
| 18 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.00396269 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96399961 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.96248580 |
| 21 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.95049734 |
| 22 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.88994901 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85517916 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83800416 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83763757 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80348604 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78917832 |
| 28 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.78448742 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77147768 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77113788 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75859872 |
| 32 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66539728 |
| 33 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.63868507 |
| 34 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63562326 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63236297 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60315557 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60158518 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59973117 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58763697 |
| 40 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58613060 |
| 41 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57592858 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57292379 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56902703 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54845432 |
| 45 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.52633605 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51789159 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51252913 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50593067 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50014382 |
| 50 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.49031229 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47865249 |
| 52 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.47129968 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45399745 |
| 54 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.45333894 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44242208 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.41795705 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40818654 |
| 58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40589298 |
| 59 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40328661 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39967235 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37127188 |
| 62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.35303412 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34167125 |
| 64 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.34105738 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33490580 |
| 66 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.32849407 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32379114 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31116226 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30150010 |
| 70 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29440594 |
| 71 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28810519 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.25974514 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25237740 |
| 74 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.23830604 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23742921 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21595020 |
| 77 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21476644 |
| 78 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20179169 |
| 79 | * MYB_26560356_Chip-Seq_TH2_Human | 1.20172211 |
| 80 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19737274 |
| 81 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.19547290 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19429857 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18849741 |
| 84 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.18075998 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17843733 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17563909 |
| 87 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.17258359 |
| 88 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17213802 |
| 89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16911635 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14862966 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14834778 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14662587 |
| 93 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.13898799 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13491198 |
| 95 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.11773816 |
| 96 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.11729294 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11300164 |
| 98 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.11090443 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10926517 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10890426 |
| 101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10567462 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10172977 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10166720 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09237378 |
| 105 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09234987 |
| 106 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08572287 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07679130 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07579515 |
| 109 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06832298 |
| 110 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06608629 |
| 111 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.06510177 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06202134 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05240786 |
| 114 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04535279 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04267926 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03931680 |
| 117 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03515809 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03243500 |
| 119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02803344 |
| 120 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02654957 |
| 121 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02627128 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02465729 |
| 123 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.02448398 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02062687 |
| 125 | P68_20966046_ChIP-Seq_HELA_Human | 1.02054736 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01592823 |
| 127 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01490876 |
| 128 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01444314 |
| 129 | MYB_26560356_Chip-Seq_TH1_Human | 1.01078852 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00591746 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00495697 |
| 132 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00078924 |
| 133 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99853089 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99557481 |
| 135 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99504931 |
| 136 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.97957515 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97895355 |
| 138 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.97521236 |
| 139 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97275848 |
| 140 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97233685 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96843718 |
| 142 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95860254 |
| 143 | MAF_26560356_Chip-Seq_TH2_Human | 0.93895405 |
| 144 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92012631 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91836440 |
| 146 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91566049 |
| 147 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90835754 |
| 148 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.89319224 |
| 149 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88748402 |
| 150 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88153428 |
| 151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87783010 |
| 152 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87725326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 3.86641901 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.75947544 |
| 3 | MP0003011_delayed_dark_adaptation | 3.55490649 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.49393515 |
| 5 | MP0005451_abnormal_body_composition | 3.25897391 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 2.79136979 |
| 7 | * MP0003763_abnormal_thymus_physiology | 2.78856467 |
| 8 | MP0003436_decreased_susceptibility_to | 2.74249641 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.40283056 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.39714645 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.33595913 |
| 12 | MP0008961_abnormal_basal_metabolism | 2.29958107 |
| 13 | MP0008260_abnormal_autophagy | 2.29101610 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.28723026 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.19667045 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.18149414 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.14260715 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.11516039 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.08994200 |
| 20 | MP0009278_abnormal_bone_marrow | 2.03077313 |
| 21 | * MP0005380_embryogenesis_phenotype | 2.02302770 |
| 22 | * MP0001672_abnormal_embryogenesis/_devel | 2.02302770 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.02231334 |
| 24 | MP0004858_abnormal_nervous_system | 1.99121757 |
| 25 | * MP0002088_abnormal_embryonic_growth/wei | 1.96496620 |
| 26 | MP0009840_abnormal_foam_cell | 1.95893861 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.95173769 |
| 28 | MP0008057_abnormal_DNA_replication | 1.93912241 |
| 29 | * MP0003984_embryonic_growth_retardation | 1.93710720 |
| 30 | MP0004947_skin_inflammation | 1.87931723 |
| 31 | MP0001800_abnormal_humoral_immune | 1.85387099 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.81969550 |
| 33 | MP0003121_genomic_imprinting | 1.81947582 |
| 34 | MP0003122_maternal_imprinting | 1.81136824 |
| 35 | MP0000685_abnormal_immune_system | 1.80785879 |
| 36 | MP0002086_abnormal_extraembryonic_tissu | 1.79794904 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.76597668 |
| 38 | MP0005387_immune_system_phenotype | 1.75035243 |
| 39 | MP0001790_abnormal_immune_system | 1.75035243 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.75006444 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.73849227 |
| 42 | MP0002398_abnormal_bone_marrow | 1.68547001 |
| 43 | MP0005499_abnormal_olfactory_system | 1.67621056 |
| 44 | MP0005394_taste/olfaction_phenotype | 1.67621056 |
| 45 | MP0005671_abnormal_response_to | 1.67607818 |
| 46 | MP0005025_abnormal_response_to | 1.66168154 |
| 47 | MP0003111_abnormal_nucleus_morphology | 1.65028626 |
| 48 | MP0002419_abnormal_innate_immunity | 1.64875700 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.63406660 |
| 50 | MP0001819_abnormal_immune_cell | 1.61666358 |
| 51 | MP0002723_abnormal_immune_serum | 1.60789026 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.60359914 |
| 53 | MP0001873_stomach_inflammation | 1.60261432 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.58150164 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.55139399 |
| 56 | MP0003123_paternal_imprinting | 1.51730294 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.50151473 |
| 58 | MP0004197_abnormal_fetal_growth/weight/ | 1.46544908 |
| 59 | MP0005670_abnormal_white_adipose | 1.44578880 |
| 60 | MP0003077_abnormal_cell_cycle | 1.43907996 |
| 61 | MP0002405_respiratory_system_inflammati | 1.43267881 |
| 62 | MP0002084_abnormal_developmental_patter | 1.43001508 |
| 63 | MP0000716_abnormal_immune_system | 1.42371083 |
| 64 | MP0001730_embryonic_growth_arrest | 1.42003994 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.41610137 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.38454060 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.38037119 |
| 68 | MP0001849_ear_inflammation | 1.37147293 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.35328536 |
| 70 | MP0002085_abnormal_embryonic_tissue | 1.34740624 |
| 71 | MP0004233_abnormal_muscle_weight | 1.34134879 |
| 72 | MP0002009_preneoplasia | 1.33829131 |
| 73 | MP0002092_abnormal_eye_morphology | 1.33112189 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.33051908 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.32091757 |
| 76 | * MP0002429_abnormal_blood_cell | 1.30524652 |
| 77 | MP0010094_abnormal_chromosome_stability | 1.29289682 |
| 78 | MP0004381_abnormal_hair_follicle | 1.27197436 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.26632774 |
| 80 | MP0005666_abnormal_adipose_tissue | 1.25733650 |
| 81 | MP0005023_abnormal_wound_healing | 1.24788214 |
| 82 | MP0005464_abnormal_platelet_physiology | 1.21324392 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 1.20253146 |
| 84 | MP0003119_abnormal_digestive_system | 1.19821650 |
| 85 | MP0000428_abnormal_craniofacial_morphol | 1.18807769 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.18680831 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.18092184 |
| 88 | MP0003303_peritoneal_inflammation | 1.17235048 |
| 89 | MP0010030_abnormal_orbit_morphology | 1.16504625 |
| 90 | MP0009785_altered_susceptibility_to | 1.15436198 |
| 91 | * MP0002080_prenatal_lethality | 1.15318369 |
| 92 | MP0002925_abnormal_cardiovascular_devel | 1.15248393 |
| 93 | MP0001545_abnormal_hematopoietic_system | 1.14283639 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 1.14283639 |
| 95 | MP0001293_anophthalmia | 1.14154389 |
| 96 | MP0001853_heart_inflammation | 1.13052597 |
| 97 | * MP0001697_abnormal_embryo_size | 1.12628936 |
| 98 | MP0008770_decreased_survivor_rate | 1.11315852 |
| 99 | MP0005266_abnormal_metabolism | 1.10263327 |
| 100 | MP0000609_abnormal_liver_physiology | 1.08134504 |
| 101 | MP0002148_abnormal_hypersensitivity_rea | 1.06479790 |
| 102 | MP0003724_increased_susceptibility_to | 1.05508695 |
| 103 | MP0003938_abnormal_ear_development | 1.05221183 |
| 104 | MP0002796_impaired_skin_barrier | 1.04761949 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.04042707 |
| 106 | MP0001533_abnormal_skeleton_physiology | 1.03690603 |
| 107 | MP0010307_abnormal_tumor_latency | 1.03219832 |
| 108 | MP0000733_abnormal_muscle_development | 1.01973645 |
| 109 | MP0005409_darkened_coat_color | 1.01603117 |
| 110 | MP0002269_muscular_atrophy | 1.00333325 |
| 111 | MP0005621_abnormal_cell_physiology | 1.00157677 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.99850217 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.98734184 |
| 114 | * MP0002970_abnormal_white_adipose | 0.97851487 |
| 115 | MP0008007_abnormal_cellular_replicative | 0.96192689 |
| 116 | MP0005360_urolithiasis | 0.94751727 |
| 117 | * MP0000490_abnormal_crypts_of | 0.94608150 |
| 118 | MP0002932_abnormal_joint_morphology | 0.94511622 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.93958569 |
| 120 | MP0004272_abnormal_basement_membrane | 0.92984884 |
| 121 | MP0000678_abnormal_parathyroid_gland | 0.91912615 |
| 122 | MP0005310_abnormal_salivary_gland | 0.91463808 |
| 123 | MP0000432_abnormal_head_morphology | 0.91380165 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.91114524 |
| 125 | MP0003935_abnormal_craniofacial_develop | 0.91040570 |
| 126 | MP0003828_pulmonary_edema | 0.89116168 |
| 127 | MP0005501_abnormal_skin_physiology | 0.88685720 |
| 128 | MP0004510_myositis | 0.88204592 |
| 129 | MP0003866_abnormal_defecation | 0.88198954 |
| 130 | MP0001851_eye_inflammation | 0.87124477 |
| 131 | MP0002006_tumorigenesis | 0.87040127 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.86491535 |
| 133 | * MP0000313_abnormal_cell_death | 0.86411918 |
| 134 | MP0003091_abnormal_cell_migration | 0.85262888 |
| 135 | MP0003448_altered_tumor_morphology | 0.85004371 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.84990160 |
| 137 | MP0002722_abnormal_immune_system | 0.83029338 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82737249 |
| 139 | MP0000604_amyloidosis | 0.82605739 |
| 140 | MP0008469_abnormal_protein_level | 0.82173940 |
| 141 | MP0004808_abnormal_hematopoietic_stem | 0.81483689 |
| 142 | MP0000750_abnormal_muscle_regeneration | 0.81349031 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.80644712 |
| 144 | MP0000858_altered_metastatic_potential | 0.80624201 |
| 145 | MP0009931_abnormal_skin_appearance | 0.80473444 |
| 146 | MP0000749_muscle_degeneration | 0.78123098 |
| 147 | MP0002139_abnormal_hepatobiliary_system | 0.76922168 |
| 148 | MP0000598_abnormal_liver_morphology | 0.76877919 |
| 149 | MP0000703_abnormal_thymus_morphology | 0.76699033 |
| 150 | MP0002019_abnormal_tumor_incidence | 0.76516189 |
| 151 | MP0003787_abnormal_imprinting | 0.76280020 |
| 152 | * MP0000266_abnormal_heart_morphology | 0.75832865 |
| 153 | MP0001216_abnormal_epidermal_layer | 0.75438839 |
| 154 | MP0005623_abnormal_meninges_morphology | 0.75223250 |
| 155 | * MP0010630_abnormal_cardiac_muscle | 0.75139519 |
| 156 | MP0005319_abnormal_enzyme/_coenzyme | 0.73571756 |
| 157 | MP0009115_abnormal_fat_cell | 0.73187149 |
| 158 | MP0006082_CNS_inflammation | 0.73107325 |
| 159 | MP0000762_abnormal_tongue_morphology | 0.69699934 |
| 160 | MP0009703_decreased_birth_body | 0.69503585 |
| 161 | MP0001915_intracranial_hemorrhage | 0.69121381 |
| 162 | MP0008932_abnormal_embryonic_tissue | 0.68291003 |
| 163 | MP0000767_abnormal_smooth_muscle | 0.67150319 |
| 164 | MP0003693_abnormal_embryo_hatching | 0.66371334 |
| 165 | MP0005375_adipose_tissue_phenotype | 0.66111748 |
| 166 | MP0000358_abnormal_cell_content/ | 0.65551403 |
| 167 | MP0003453_abnormal_keratinocyte_physiol | 0.65430909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 5.28920378 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.12636878 |
| 3 | Abnormality of the lower motor neuron (HP:0002366) | 4.67670571 |
| 4 | Multiple enchondromatosis (HP:0005701) | 4.36551568 |
| 5 | Ependymoma (HP:0002888) | 4.27388499 |
| 6 | Hepatoblastoma (HP:0002884) | 3.88254904 |
| 7 | Rib fusion (HP:0000902) | 3.75456217 |
| 8 | Neoplasm of striated muscle (HP:0009728) | 3.75118301 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.65637117 |
| 10 | Rhabdomyosarcoma (HP:0002859) | 3.48018773 |
| 11 | Increased connective tissue (HP:0009025) | 3.17457491 |
| 12 | Pseudobulbar signs (HP:0002200) | 3.12858957 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.95908602 |
| 14 | Abnormality of the astrocytes (HP:0100707) | 2.92015381 |
| 15 | Astrocytoma (HP:0009592) | 2.92015381 |
| 16 | Colitis (HP:0002583) | 2.87654174 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.86768094 |
| 18 | Preauricular skin tag (HP:0000384) | 2.84162161 |
| 19 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.84108999 |
| 20 | Cellulitis (HP:0100658) | 2.83730011 |
| 21 | Impulsivity (HP:0100710) | 2.82158769 |
| 22 | Difficulty running (HP:0009046) | 2.80110477 |
| 23 | Skin tags (HP:0010609) | 2.78103295 |
| 24 | Hyperacusis (HP:0010780) | 2.76482749 |
| 25 | Hypopigmentation of the fundus (HP:0007894) | 2.75639036 |
| 26 | Intestinal fistula (HP:0100819) | 2.73325968 |
| 27 | Broad face (HP:0000283) | 2.71121216 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.70372662 |
| 29 | Achilles tendon contracture (HP:0001771) | 2.69864612 |
| 30 | Hypochromic anemia (HP:0001931) | 2.67184885 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.66624538 |
| 32 | Distal lower limb amyotrophy (HP:0008944) | 2.65658509 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.64968453 |
| 34 | Recurrent viral infections (HP:0004429) | 2.63878671 |
| 35 | Heterotopia (HP:0002282) | 2.61370281 |
| 36 | Abnormality of the Achilles tendon (HP:0005109) | 2.60229335 |
| 37 | Embryonal renal neoplasm (HP:0011794) | 2.57701048 |
| 38 | Partial duplication of thumb phalanx (HP:0009944) | 2.53484973 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.53110995 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 2.52875486 |
| 41 | Abnormality of the salivary glands (HP:0010286) | 2.52344703 |
| 42 | Rectovaginal fistula (HP:0000143) | 2.50612687 |
| 43 | Rectal fistula (HP:0100590) | 2.50612687 |
| 44 | Large earlobe (HP:0009748) | 2.49901106 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.49378929 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.48382786 |
| 47 | Chromsome breakage (HP:0040012) | 2.47826249 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.47793033 |
| 49 | Increased IgE level (HP:0003212) | 2.47465844 |
| 50 | Short humerus (HP:0005792) | 2.43931364 |
| 51 | Nasal polyposis (HP:0100582) | 2.42997233 |
| 52 | Renal duplication (HP:0000075) | 2.42930960 |
| 53 | Fused cervical vertebrae (HP:0002949) | 2.41744284 |
| 54 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.34901411 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.33193661 |
| 56 | Horizontal nystagmus (HP:0000666) | 2.32946817 |
| 57 | Partial duplication of the phalanx of hand (HP:0009999) | 2.31633706 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.30305414 |
| 59 | Generalized hypotonia (HP:0001290) | 2.30287835 |
| 60 | Supernumerary ribs (HP:0005815) | 2.30186103 |
| 61 | Fatigue (HP:0012378) | 2.30145466 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.26927182 |
| 63 | Trismus (HP:0000211) | 2.26176468 |
| 64 | Thin bony cortex (HP:0002753) | 2.25602799 |
| 65 | Vaginal fistula (HP:0004320) | 2.23544432 |
| 66 | Meckel diverticulum (HP:0002245) | 2.21290333 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.18620743 |
| 68 | Periauricular skin pits (HP:0100277) | 2.17635617 |
| 69 | Preauricular pit (HP:0004467) | 2.17635617 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13770127 |
| 71 | Obstructive lung disease (HP:0006536) | 2.13770127 |
| 72 | Neoplasm of the heart (HP:0100544) | 2.12250057 |
| 73 | Hand muscle atrophy (HP:0009130) | 2.11095988 |
| 74 | Hyperglycinuria (HP:0003108) | 2.10941442 |
| 75 | Meningitis (HP:0001287) | 2.10585326 |
| 76 | Abnormality of the thoracic spine (HP:0100711) | 2.10400008 |
| 77 | Abnormality of oral frenula (HP:0000190) | 2.07988731 |
| 78 | Gingivitis (HP:0000230) | 2.07532161 |
| 79 | Upper motor neuron abnormality (HP:0002127) | 2.07380380 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06017097 |
| 81 | Disproportionate tall stature (HP:0001519) | 2.04942420 |
| 82 | Abnormality of the ileum (HP:0001549) | 2.04867879 |
| 83 | Spinal cord lesions (HP:0100561) | 2.04797616 |
| 84 | Syringomyelia (HP:0003396) | 2.04797616 |
| 85 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.04402077 |
| 86 | Dislocated radial head (HP:0003083) | 2.03965451 |
| 87 | Abnormality of the musculature of the hand (HP:0001421) | 2.01591469 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.01220046 |
| 89 | Reticulocytosis (HP:0001923) | 2.00643680 |
| 90 | EMG: neuropathic changes (HP:0003445) | 2.00450513 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 1.99244173 |
| 92 | Distal upper limb amyotrophy (HP:0007149) | 1.99123569 |
| 93 | Upper limb amyotrophy (HP:0009129) | 1.99123569 |
| 94 | Glioma (HP:0009733) | 1.98654334 |
| 95 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98488571 |
| 96 | Short 5th finger (HP:0009237) | 1.98248362 |
| 97 | Cerebral aneurysm (HP:0004944) | 1.98215854 |
| 98 | Flat acetabular roof (HP:0003180) | 1.97255854 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 1.96808304 |
| 100 | Thoracic kyphosis (HP:0002942) | 1.95827496 |
| 101 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.95801853 |
| 102 | Myositis (HP:0100614) | 1.95434271 |
| 103 | Protrusio acetabuli (HP:0003179) | 1.94957479 |
| 104 | Abnormality of chromosome segregation (HP:0002916) | 1.94806256 |
| 105 | Adenoma sebaceum (HP:0009720) | 1.94261272 |
| 106 | Angiofibromas (HP:0010615) | 1.94261272 |
| 107 | Medulloblastoma (HP:0002885) | 1.94194904 |
| 108 | Slow saccadic eye movements (HP:0000514) | 1.91150730 |
| 109 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.90945042 |
| 110 | Missing ribs (HP:0000921) | 1.90156451 |
| 111 | Abnormal lung lobation (HP:0002101) | 1.90091461 |
| 112 | Prominent occiput (HP:0000269) | 1.90077321 |
| 113 | Selective tooth agenesis (HP:0001592) | 1.89605526 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.88853958 |
| 115 | Villous atrophy (HP:0011473) | 1.86597712 |
| 116 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86597712 |
| 117 | Myopathic facies (HP:0002058) | 1.85699279 |
| 118 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.85287956 |
| 119 | Prominent nose (HP:0000448) | 1.85024306 |
| 120 | Ulnar bowing (HP:0003031) | 1.84513156 |
| 121 | Supernumerary spleens (HP:0009799) | 1.84466335 |
| 122 | T lymphocytopenia (HP:0005403) | 1.84301776 |
| 123 | Vertebral fusion (HP:0002948) | 1.83780729 |
| 124 | Long palpebral fissure (HP:0000637) | 1.83564668 |
| 125 | Hemiparesis (HP:0001269) | 1.83229115 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.83160329 |
| 127 | Abnormality of the radial head (HP:0003995) | 1.83156326 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.82730951 |
| 129 | Skin pits (HP:0100276) | 1.82662997 |
| 130 | Hypertensive crisis (HP:0100735) | 1.81721072 |
| 131 | Dysmetric saccades (HP:0000641) | 1.81185535 |
| 132 | Hemorrhage of the eye (HP:0011885) | 1.81121418 |
| 133 | Upper limb muscle weakness (HP:0003484) | 1.80921117 |
| 134 | Increased nuchal translucency (HP:0010880) | 1.79543845 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79373831 |
| 136 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79351594 |
| 137 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.79326686 |
| 138 | Viral hepatitis (HP:0006562) | 1.79301577 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.79071452 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.78417248 |
| 141 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.78372417 |
| 142 | Recurrent skin infections (HP:0001581) | 1.78069143 |
| 143 | Ankyloglossia (HP:0010296) | 1.77818514 |
| 144 | Hypoplasia of the fovea (HP:0007750) | 1.77580998 |
| 145 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77580998 |
| 146 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77330410 |
| 147 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.76126248 |
| 148 | Lymphangioma (HP:0100764) | 1.75798070 |
| 149 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.75311794 |
| 150 | Loss of speech (HP:0002371) | 1.75008655 |
| 151 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73217600 |
| 152 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73217600 |
| 153 | Broad alveolar ridges (HP:0000187) | 1.72111426 |
| 154 | Emphysema (HP:0002097) | 1.72074264 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.71696431 |
| 156 | Atresia of the external auditory canal (HP:0000413) | 1.71188568 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.69934090 |
| 158 | Deep palmar crease (HP:0006191) | 1.68080568 |
| 159 | Abnormality of the peritoneum (HP:0002585) | 1.68072503 |
| 160 | Ventricular tachycardia (HP:0004756) | 1.67663366 |
| 161 | Osteomyelitis (HP:0002754) | 1.67092371 |
| 162 | Dilatation of the ascending aorta (HP:0005111) | 1.67005663 |
| 163 | Lower limb amyotrophy (HP:0007210) | 1.66056057 |
| 164 | Subacute progressive viral hepatitis (HP:0006572) | 1.65646398 |
| 165 | Osteolytic defects of the hand bones (HP:0009699) | 1.65616872 |
| 166 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65616872 |
| 167 | Stridor (HP:0010307) | 1.64753405 |
| 168 | Pustule (HP:0200039) | 1.64381257 |
| 169 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.63776757 |
| 170 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63776757 |
| 171 | Abnormality of glycolipid metabolism (HP:0010969) | 1.63776757 |
| 172 | Biconcave vertebral bodies (HP:0004586) | 1.63621151 |
| 173 | Orchitis (HP:0100796) | 1.63474067 |
| 174 | Papilloma (HP:0012740) | 1.62878001 |
| 175 | Verrucae (HP:0200043) | 1.62878001 |
| 176 | Obstructive sleep apnea (HP:0002870) | 1.62613012 |
| 177 | Metaphyseal cupping (HP:0003021) | 1.61557143 |
| 178 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.60269029 |
| 179 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.60154921 |
| 180 | Persistence of primary teeth (HP:0006335) | 1.58565834 |
| 181 | Lymphopenia (HP:0001888) | 1.58021804 |
| 182 | Abnormality of the calcaneus (HP:0008364) | 1.57563328 |
| 183 | Polygenic inheritance (HP:0010982) | 1.56964993 |
| 184 | Exercise-induced myalgia (HP:0003738) | 1.56456675 |
| 185 | Broad distal phalanx of finger (HP:0009836) | 1.56005079 |
| 186 | Vasculitis (HP:0002633) | 1.55563199 |
| 187 | Aneurysm (HP:0002617) | 1.55224101 |
| 188 | Abnormal gallbladder physiology (HP:0012438) | 1.52383547 |
| 189 | Cholecystitis (HP:0001082) | 1.52383547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.59687160 |
| 2 | ERN1 | 3.92517650 |
| 3 | PRPF4B | 3.92136732 |
| 4 | GRK6 | 3.77799092 |
| 5 | SMG1 | 3.33243965 |
| 6 | GRK5 | 2.91517471 |
| 7 | MAP3K10 | 2.77197676 |
| 8 | IRAK3 | 2.50176799 |
| 9 | STK10 | 2.45917137 |
| 10 | TYRO3 | 2.32942582 |
| 11 | TGFBR2 | 2.32649822 |
| 12 | CSF1R | 2.24315220 |
| 13 | GRK1 | 2.10774793 |
| 14 | TRIB3 | 2.08265129 |
| 15 | TTK | 2.00243893 |
| 16 | PKN2 | 1.86555300 |
| 17 | RIPK4 | 1.82507682 |
| 18 | MAP3K13 | 1.77557085 |
| 19 | TYK2 | 1.67199823 |
| 20 | MAPK7 | 1.60475131 |
| 21 | MAP3K14 | 1.51349923 |
| 22 | EEF2K | 1.51049524 |
| 23 | TLK1 | 1.50250480 |
| 24 | IRAK4 | 1.44307298 |
| 25 | WNK1 | 1.41852609 |
| 26 | TAOK2 | 1.40442669 |
| 27 | MAP3K7 | 1.39199439 |
| 28 | TTN | 1.36697831 |
| 29 | FGFR3 | 1.31200167 |
| 30 | NEK2 | 1.30811033 |
| 31 | MATK | 1.26524050 |
| 32 | CDK7 | 1.24529373 |
| 33 | MAP3K3 | 1.22489516 |
| 34 | RIPK1 | 1.19672392 |
| 35 | CAMK4 | 1.18879593 |
| 36 | KSR2 | 1.18186305 |
| 37 | ALK | 1.17258763 |
| 38 | MARK2 | 1.15433472 |
| 39 | MAP3K11 | 1.13870149 |
| 40 | MOS | 1.11902438 |
| 41 | TBK1 | 1.11709046 |
| 42 | PAK4 | 1.10948137 |
| 43 | JAK3 | 1.10739478 |
| 44 | ADRBK2 | 1.10725984 |
| 45 | EPHA2 | 1.09998872 |
| 46 | CSK | 1.08828650 |
| 47 | MAP4K1 | 1.08251035 |
| 48 | CDC42BPA | 1.07960740 |
| 49 | PDGFRA | 1.06526703 |
| 50 | MTOR | 1.06350132 |
| 51 | MAP3K1 | 1.06119774 |
| 52 | HIPK2 | 1.05700506 |
| 53 | TESK2 | 1.04875536 |
| 54 | CDK4 | 1.04010104 |
| 55 | PRKG2 | 1.03288205 |
| 56 | PRKD2 | 1.02752055 |
| 57 | BTK | 1.02558938 |
| 58 | FES | 1.00825530 |
| 59 | ICK | 0.95539101 |
| 60 | CDC7 | 0.95524076 |
| 61 | SCYL2 | 0.90915145 |
| 62 | GRK7 | 0.90208242 |
| 63 | BMX | 0.88538980 |
| 64 | STK38 | 0.87012089 |
| 65 | SIK1 | 0.86666181 |
| 66 | PIM2 | 0.84020967 |
| 67 | RPS6KB2 | 0.83990762 |
| 68 | PDPK1 | 0.81652644 |
| 69 | NTRK1 | 0.81402952 |
| 70 | IRAK2 | 0.81184139 |
| 71 | JAK1 | 0.80661150 |
| 72 | BRD4 | 0.80638766 |
| 73 | CHEK2 | 0.78858080 |
| 74 | PDK3 | 0.77639734 |
| 75 | PDK4 | 0.77639734 |
| 76 | CHEK1 | 0.76225791 |
| 77 | ITK | 0.73478799 |
| 78 | AKT2 | 0.72980524 |
| 79 | FGFR4 | 0.70409351 |
| 80 | PLK1 | 0.69689614 |
| 81 | RAF1 | 0.69505512 |
| 82 | MAPK12 | 0.68889929 |
| 83 | EPHB1 | 0.68857544 |
| 84 | IKBKE | 0.68621105 |
| 85 | CLK1 | 0.68545143 |
| 86 | RPS6KC1 | 0.67911903 |
| 87 | RPS6KL1 | 0.67911903 |
| 88 | MAP2K4 | 0.67664300 |
| 89 | SIK3 | 0.64804017 |
| 90 | MELK | 0.63641246 |
| 91 | MKNK2 | 0.62172777 |
| 92 | FLT3 | 0.61768918 |
| 93 | ARAF | 0.61636075 |
| 94 | PTK6 | 0.61400563 |
| 95 | MAP3K8 | 0.59379358 |
| 96 | MST1R | 0.59256898 |
| 97 | SIK2 | 0.58935374 |
| 98 | DYRK1B | 0.58146779 |
| 99 | PTK2 | 0.57307719 |
| 100 | MAP3K6 | 0.54178705 |
| 101 | RPS6KA2 | 0.54069355 |
| 102 | BLK | 0.52806005 |
| 103 | MAP2K3 | 0.52319577 |
| 104 | SYK | 0.51174261 |
| 105 | CDK2 | 0.49867220 |
| 106 | MAP2K2 | 0.49791759 |
| 107 | LCK | 0.49571726 |
| 108 | MAPK11 | 0.49323100 |
| 109 | STK4 | 0.48821818 |
| 110 | CDK6 | 0.48438511 |
| 111 | HCK | 0.47368023 |
| 112 | PAK2 | 0.47358492 |
| 113 | TNK2 | 0.47277155 |
| 114 | RPS6KA6 | 0.45465492 |
| 115 | KDR | 0.44110073 |
| 116 | CAMKK1 | 0.43980452 |
| 117 | CAMK1D | 0.43886010 |
| 118 | FGR | 0.42585023 |
| 119 | WEE1 | 0.42044087 |
| 120 | RET | 0.40614742 |
| 121 | MAPKAPK3 | 0.40316741 |
| 122 | CDK8 | 0.39316601 |
| 123 | CAMK1G | 0.39279556 |
| 124 | LRRK2 | 0.39049169 |
| 125 | ATM | 0.38805772 |
| 126 | PRKAA2 | 0.38610745 |
| 127 | AURKB | 0.38462143 |
| 128 | TXK | 0.38340206 |
| 129 | JAK2 | 0.37809122 |
| 130 | MAPKAPK2 | 0.37605849 |
| 131 | PIM1 | 0.37494528 |
| 132 | TAOK1 | 0.36611379 |
| 133 | ERBB2 | 0.35990032 |
| 134 | MAP2K6 | 0.33768933 |
| 135 | ADRBK1 | 0.31875535 |
| 136 | MARK3 | 0.31094321 |
| 137 | PDGFRB | 0.31041255 |
| 138 | CHUK | 0.29811647 |
| 139 | ZAP70 | 0.29613933 |
| 140 | IGF1R | 0.29351832 |
| 141 | PRKAA1 | 0.28959966 |
| 142 | MAP3K9 | 0.28932802 |
| 143 | PRKD3 | 0.28838595 |
| 144 | PRKCI | 0.28604009 |
| 145 | NME2 | 0.28060645 |
| 146 | MAPK10 | 0.27792607 |
| 147 | MAPK1 | 0.27414065 |
| 148 | PDK1 | 0.27401673 |
| 149 | INSR | 0.26922757 |
| 150 | PRKD1 | 0.25924172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.83855555 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.63416608 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.42455002 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.42066027 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.41987284 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.11951696 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02757933 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80160164 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 1.72872771 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70849279 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.69310093 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.65508850 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62639213 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59675056 |
| 15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53096923 |
| 16 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.52883593 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52766112 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.50616563 |
| 19 | Hepatitis B_Homo sapiens_hsa05161 | 1.46681255 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44295627 |
| 21 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.44049487 |
| 22 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42070807 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.39183098 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38262866 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36082329 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32918375 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27799283 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27640694 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27312506 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.26052490 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.25856590 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.24733103 |
| 33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24018245 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21952711 |
| 35 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.21832217 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.20735557 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18391691 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17130343 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16794990 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15718377 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15334550 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15261899 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11630204 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11214374 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10868629 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.10804599 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10616313 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.10298620 |
| 49 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.09435607 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.07475277 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07474155 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07428764 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07415751 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06994590 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06652778 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06569724 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05634234 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.02907048 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02403919 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00601982 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99631244 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99366143 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98967178 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98561433 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98215968 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.98147083 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97791068 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97568801 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.95403053 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93732270 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93450537 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93371591 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93200336 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92165689 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.91936709 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.91619211 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91352474 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.90873015 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90834109 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.90660565 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90453559 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89494798 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89068221 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83840468 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.83810097 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83690076 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83411138 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83356458 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82781629 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82589083 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82547663 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.81634849 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81568344 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81264109 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81223330 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.80684656 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80596336 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79121110 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78115377 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77649798 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.77146552 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77079904 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77064751 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76297629 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75797377 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74998733 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74098933 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73735261 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72848854 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72600863 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71980443 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71662972 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71446659 |
| 114 | Cell cycle_Homo sapiens_hsa04110 | 0.71384966 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71335861 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.70963962 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70713304 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.69938948 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68988721 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67913412 |
| 121 | Homologous recombination_Homo sapiens_hsa03440 | 0.67306260 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67264140 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67236387 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.66415821 |
| 125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65463912 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64477746 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63634263 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63326273 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61726965 |
| 130 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61211569 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61145319 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60881175 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60364316 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.59945524 |
| 135 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58882904 |
| 136 | Spliceosome_Homo sapiens_hsa03040 | 0.58624703 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58506926 |
| 138 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58183412 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.56508625 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54390336 |
| 141 | Focal adhesion_Homo sapiens_hsa04510 | 0.53880661 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.53672202 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51020937 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.50786563 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50150672 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50035549 |
| 147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48271950 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48076647 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47632776 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47407823 |
| 151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46825210 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45598440 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45137460 |
| 154 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45044576 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43840641 |

